We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
American Bio Medica Corporation (CE) | USOTC:ABMC | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
|
(a)
|
The reasons
described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or expense;
|
☒
|
(b)
|
The subject annual
report, semi-annual report, transition report on Form 10-K, Form
20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will
be filed on or before the fifteenth calendar day following the
prescribed due date, or the subject quarterly report on Form 10-Q
or subject distribution report on Form 10-D, or portion thereof,
will be filed on or before the fifth calendar day following the
prescribed due date; and
|
|
(c)
|
The accountant's
statement or other exhibit required by Rule 12b-25(c) has been
attached if applicable.
|
Melissa A.
Waterhouse
|
(518)
|
758-8158
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
|
|
|
|
|
|
|
|
Date:
May 17, 2021
|
By:
|
/s/ Melissa A.
Waterhouse
|
|
|
|
Melissa A. Waterhouse |
|
|
|
Chief Executive
Officer/ Principal Financial Officer
|
|
1 Year American Bio Medica (CE) Chart |
1 Month American Bio Medica (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions